In general, folding of AR to a mature hormone binding conformation is a highly ordered, dynamic assembly of heteromeric complexes that involves multiple chaperone and co‐chaperone components (Smith and Toft, 2008), most of which represent potential targets for the treatment of prostate cancer (Cano et al., 2013). The gene discussed is AR; the disease is prostate cancer.